ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,300.70
0.54%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Hillstream BioPharma Inc (HILS)

  7. Hillstream BioPharma Inc (HILS) Noticias

HILS

Hillstream BioPharma (HILS)

Hillstream BioPharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HILS
FechaHoraFuenteTítuloSímboloCompañía
22/03/202410:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HILSHillstream BioPharma Inc
22/03/202410:08Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:HILSHillstream BioPharma Inc
21/03/202416:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HILSHillstream BioPharma Inc
25/09/202315:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HILSHillstream BioPharma Inc
21/09/202308:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:HILSHillstream BioPharma Inc
11/09/202310:51GlobeNewswire Inc.Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic PruritisNASDAQ:HILSHillstream BioPharma Inc
08/09/202313:30GlobeNewswire Inc.Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13NASDAQ:HILSHillstream BioPharma Inc
18/08/202316:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HILSHillstream BioPharma Inc
11/08/202315:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HILSHillstream BioPharma Inc
09/08/202307:47GlobeNewswire Inc.Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023NASDAQ:HILSHillstream BioPharma Inc
20/07/202307:00GlobeNewswire Inc.Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215NASDAQ:HILSHillstream BioPharma Inc
10/07/202307:47GlobeNewswire Inc.Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and BiologicsNASDAQ:HILSHillstream BioPharma Inc
06/07/202307:30GlobeNewswire Inc.Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian CancersNASDAQ:HILSHillstream BioPharma Inc
20/06/202315:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HILSHillstream BioPharma Inc
22/05/202305:01Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:HILSHillstream BioPharma Inc
22/05/202305:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HILSHillstream BioPharma Inc
16/05/202315:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:HILSHillstream BioPharma Inc
15/05/202315:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HILSHillstream BioPharma Inc
15/05/202307:47GlobeNewswire Inc.Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly AndersonNASDAQ:HILSHillstream BioPharma Inc
02/05/202315:05GlobeNewswire Inc.Hillstream BioPharma Announces Closing of Public Offering of Common StockNASDAQ:HILSHillstream BioPharma Inc
02/05/202307:47GlobeNewswire Inc.Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry ConferencesNASDAQ:HILSHillstream BioPharma Inc
01/05/202305:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:HILSHillstream BioPharma Inc
27/04/202320:50GlobeNewswire Inc.Hillstream BioPharma Announces Pricing of Public OfferingNASDAQ:HILSHillstream BioPharma Inc
27/04/202316:07Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:HILSHillstream BioPharma Inc
27/04/202315:00GlobeNewswire Inc.Hillstream BioPharma Announces Proposed Public OfferingNASDAQ:HILSHillstream BioPharma Inc
13/04/202307:47GlobeNewswire Inc.Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer MechanismNASDAQ:HILSHillstream BioPharma Inc
10/04/202307:47GlobeNewswire Inc.Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical DataNASDAQ:HILSHillstream BioPharma Inc
28/03/202307:47GlobeNewswire Inc.Hillstream BioPharma to Participate in Two Major Industry Conferences in April 2023NASDAQ:HILSHillstream BioPharma Inc
17/03/202316:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HILSHillstream BioPharma Inc
16/03/202316:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HILSHillstream BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:HILS

Su Consulta Reciente

EU
V514S
V514S
LSE
58YF
Morgan St. 26
LSE
81KG
Mit.sec.3.50%
BMF
DIIF25V26
DIIF25V26 - 01/2025
BIT
S29281
Societe Generale Effekten
NYSE
HOUS
Anywhere Real Estate
COIN
BOXXEUR
Blockparty
BOV
FMXB34
Femsa DRN
LSE
ONG
Oxford Nutrascience
NASDAQ
VERY
Vericity
EU
9210T
9210T
BOV
SUZBE505
SUZBE505 Ex:50,51
USOTC
HAWEL
Hawaiian Electric (PK)
EU
0672T
0672T
TSXV
NLTA.H
Enlighta
NYSE
TEO
Telecom Argentina
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados